The number of people with susceptibility test result for rifampicin in Afghanistan
Afghanistan: The number of people with susceptibility test result for rifampicin was 70.58 in 2021. ▲ Rising
Latest (2021)
70.58
Change on year
up 57.3%
World rank
103rd
of 146 countries
All-time high
70.58
in 2021
All-time low
14.93
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Afghanistan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Afghanistan stood at 70.58. That is the highest value across all 5 years on record.
The figure is up 57.3% on the previous year and up 372.8% over five years.
That places Afghanistan 103rd out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Afghanistan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 14.93 | — |
| 2018 | 48.97 | +228.1% |
| 2019 | 22.35 | -54.4% |
| 2020 | 44.87 | +100.8% |
| 2021 | 70.58 | +57.3% |
Afghanistan compared with similar countries
- Afghanistan's 70.58 is above the median for low income countries, which is 37.16, 1.9× the median. (13 countries reporting)
- Afghanistan's 70.58 is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 89, 79% of the median. (15 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 28.75 | 14.93 | 48.97 | 3 |
| 2020s | 57.72 | 44.87 | 70.58 | 2 |
Countries ranked near Afghanistan
- 100 Nigeria 76 compare
- 101 Uganda 74.76 compare
- 102 Indonesia 72.55 compare
- 104 United Arab Emirates 69.7 compare
- 105 Cape Verde 69.01 compare
- 106 Burkina Faso 67.26 compare
More health data for Afghanistan
- Un projection of annual infant deaths, annual growth rate -1.45 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.03 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 812.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 14,735 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 19 (2025)
- Population ages 00-04, female, annual growth rate 1.78 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0002 units per US$ of GDP (2024)
- Population ages 00-04, female, per capita 0.077 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.75 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0002 units per US$ of GDP (2024)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Afghanistan?
- The number of people with susceptibility test result for rifampicin in Afghanistan was 70.58 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Afghanistan?
- The highest recorded value was 70.58 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Afghanistan?
- The lowest recorded value was 14.93 in 2017.
- How does Afghanistan rank for the number of people with susceptibility test result for rifampicin?
- Afghanistan ranks 103rd out of 146 countries with data for 2021.
- Where does this Afghanistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).